Literature DB >> 192440

Oral fluorouracil therapy of hepatoma.

P S Kennedy, D E Lehane, F E Smith, M Lane.   

Abstract

Oral fluorouracil was administered weekly to 12 consecutive patients with unresectable hepatoma. Six patients showed an objective response with a significant increase in survival duration compared to nonresponders and to untreated patients. The clinical features of these cases are discussed, along with details of therapy, and possible reasons for the encouraging results noted with this treatment regimen.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 192440     DOI： 10.1002/1097-0142(197705)39:5<1930::aid-cncr2820390503>3.0.co;2-7

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


  4 in total

1.  Clinical decision analysis using microcomputers. A case of coexistent hepatocellular carcinoma and abdominal aortic aneurysm.

Authors:  J B Wong; A J Moskowitz; S G Pauker
Journal:  West J Med       Date:  1986-12

2.  The design and cytotoxic evaluation of some 1-aryl-3-isopropylamino-1-propanone hydrochlorides towards human Huh-7 hepatoma cells.

Authors:  Ebru Mete; H Inci Gul; Rengul Cetin-Atalay; Umashankar Das; Ertan Sahin; Mustafa Gul; Cavit Kazaz; Jonathan R Dimmock
Journal:  Arch Pharm (Weinheim)       Date:  2011-02-14       Impact factor: 3.751

3.  Right trisegmentectomy for hepatic neoplasms.

Authors:  T E Starzl; L J Koep; R Weil; J R Lilly; C W Putnam; J A Aldrete
Journal:  Surg Gynecol Obstet       Date:  1980-02

4.  Clinical study of biological response modifiers as maintenance therapy for hepatocellular carcinoma.

Authors:  T Suto; S Fukuda; N Moriya; Y Watanabe; D Sasaki; Y Yoshida; Y Sakata
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.